Quick Takeaways
- David E. Lazar has 12 issuer positions tracked on this page.
- Estimated disclosed ownership value: $48,637,612.
- Recent insider filing activity is available below.
Insider Trading & Ownership of David E. Lazar
- Location
- Panama City
- Summary
- The estimated net worth of David E. Lazar is at least $48,637,612 dollars as of 01 May 2026. David E. Lazar is the 10%+ Owner of NovaBay Pharmaceuticals, Inc. and owns shares of Stablecoin Development Corp (SDEV) stock worth about $36.03M. David E. Lazar is the Director, 10%+ Owner of MINIM, INC. and owns shares of FiEE, Inc. (FIEE) stock worth about $7.28M. David E. Lazar is the Director of Sow Good Inc. and owns shares of Sow Good Inc. (SOWG) stock worth about $4.98M. David E. Lazar is the Chief Executive Officer, Director of TITAN PHARMACEUTICALS INC and owns shares of TITAN PHARMACEUTICALS INC stock worth about $123K. David E. Lazar is the President, Director of LQR House Inc. and owns shares of LQR House Inc. (YHC) stock worth about $99K. David E. Lazar is the Chief Executive Officer, Director, 10%+ Owner of OPGEN INC and owns shares of CapForce Inc. (CFOR) stock worth about $85K. David E. Lazar is the 10%+ Owner of Cyclacel Pharmaceuticals, Inc. and owns shares of Bio Green Med Solution, Inc. (BGMS) stock worth about $49.9K.
- Signature
- /s/ David E. Lazar
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David E. Lazar and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: NovaBay Pharmaceuticals, Inc. ($36,028,320).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David E. Lazar
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SDEV, NBY | NovaBay Pharmaceuticals, Inc. | 10%+ Owner | $36,028,320 | 21 Oct 2025 | ||
| FIEE | MINIM, INC. | Director, 10%+ Owner | $7,277,290 | 18 Feb 2025 | ||
| SOWG | Sow Good Inc. | Director | $4,975,134 | 31 Mar 2026 | ||
| TTNP | TITAN PHARMACEUTICALS INC | Chief Executive Officer, Director | $123,000 | 26 Jul 2023 | ||
| YHC | LQR House Inc. | President, Director | $99,000 | 02 Apr 2025 | ||
| CFOR | OPGEN INC | Chief Executive Officer, Director, 10%+ Owner | $85,000 | 30 Jul 2024 | ||
| BGMS, BGMSP | Cyclacel Pharmaceuticals, Inc. | 10%+ Owner | $49,868 | 30 Jul 2025 | ||
| ATER | Aterian, Inc. | Director | $0 | 27 Apr 2026 | ||
| INDP | Indaptus Therapeutics, Inc. | Director | $0 | 23 Mar 2026 | ||
| KALA | KALA BIO, Inc. | Chief Executive Officer, Director | $0 | 18 Dec 2025 | ||
| QUCY | MAINZ BIOMED N.V. | Chief Executive Officer, Director, 10%+ Owner | $0 | 22 Apr 2026 | ||
| TCON | Tracon Pharmaceuticals, Inc. | Chief Business Dev Officer | 07 May 2024 |
Insider Transactions Reported by David E. Lazar:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.